These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 10050549)

  • 21. [The activity of NK and K cells in mice vaccinated against plague].
    Solokhin EV; Pchelintsev SIu; Iurov SV; Uraeva VI; Afanas'ev SS; Vorob'ev AA
    Zh Mikrobiol Epidemiol Immunobiol; 1994; (4):42-5. PubMed ID: 7992534
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Yersinia pestis F1 antigen: a correlation between antibody titres and subclass distribution with differential avidity in different inbred mouse strains.
    Sabhnani L; Manocha M; Tomar D; Shashikiran D; Rao DN
    Int Immunopharmacol; 2003 Oct; 3(10-11):1413-8. PubMed ID: 12946437
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [The modifying action of normal human blood serum on vaccinal EV76 and virulent 363(1/1479) strains of Yersinia pestis].
    Ziuzina VP; Tynianova VI; Kravtsov AN; Khodova VA
    Mikrobiol Zh (1978); 1988; 50(5):87-92. PubMed ID: 3249590
    [No Abstract]   [Full Text] [Related]  

  • 24. [The effect of different Yersinia pestis antigens on the cellular link in immunity].
    Isupov IV; Nazarova LS; Pavlova LP; Gor'kova AV; Revazova ES; Dushkin VA; Zadumina SIu; Surikov NN; Taranenko TM; Dzhaparidze MN
    Zh Mikrobiol Epidemiol Immunobiol; 1990 Sep; (9):85-9. PubMed ID: 2256408
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Salmonella-based plague vaccines for bioterrorism.
    Calhoun LN; Kwon YM
    J Microbiol Immunol Infect; 2006 Apr; 39(2):92-7. PubMed ID: 16604240
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Transcriptional profiling of a mice plague model: insights into interaction between Yersinia pestis and its host.
    Liu H; Wang H; Qiu J; Wang X; Guo Z; Qiu Y; Zhou D; Han Y; Du Z; Li C; Song Y; Yang R
    J Basic Microbiol; 2009 Feb; 49(1):92-9. PubMed ID: 18759226
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Small protective fragments of the Yersinia pestis V antigen.
    Vernazza C; Lingard B; Flick-Smith HC; Baillie LW; Hill J; Atkins HS
    Vaccine; 2009 May; 27(21):2775-80. PubMed ID: 19366573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The F1 and V subunit vaccine protects against plague in the absence of IL-4 driven immune responses.
    Elvin SJ; Williamson ED
    Microb Pathog; 2000 Oct; 29(4):223-30. PubMed ID: 10993741
    [No Abstract]   [Full Text] [Related]  

  • 29. [The isolation and characteristics of variant plague microbes not producing the capsular antigen].
    Gvozdenko NA; Ryzhkov VIu; Pavlovich NV
    Mikrobiol Zh (1978); 1990; 52(6):13-7. PubMed ID: 2097497
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [The expression of Fc gamma receptors on the surface of macrophages activated by a vaccinal strain of Yersinia pestis].
    Vasil'eva GI; Tkachenko LN; Doroshenko EP; Gamleshko KhP; Balatskaia TA
    Mikrobiol Zh (1978); 1990; 52(2):84-8. PubMed ID: 2142978
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Pleiotropic effects of the lpxM mutation in Yersinia pestis resulting in modification of the biosynthesis of major immunoreactive antigens.
    Feodorova VA; Pan'kina LN; Savostina EP; Kuznetsov OS; Konnov NP; Sayapina LV; Dentovskaya SV; Shaikhutdinova RZ; Ageev SA; Lindner B; Kondakova AN; Bystrova OV; Kocharova NA; Senchenkova SN; Holst O; Pier GB; Knirel YA; Anisimov AP; Motin VL
    Vaccine; 2009 Apr; 27(16):2240-50. PubMed ID: 19428838
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The potentiating action of artificial immunodeficiency on the development of amyloidosis in plague in great gerbils].
    Zadumina SIu; Isupov IV
    Arkh Patol; 1990; 52(5):46-50. PubMed ID: 2396918
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reaction of macrophage disappearance as a method for the evaluation of cellular immunity in experimental plague.
    Vasilieva GI; Kisileva AK; Doroshenko YP; Pustovalov VL
    J Hyg Epidemiol Microbiol Immunol; 1992; 36(1):123-8. PubMed ID: 1619289
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The dependence of the inducing action of Yersinia pestis antigens on cachectin synthesis and production by mouse mononuclear phagocytes].
    Kiselev IuL; Isin ZhM; Tugambaev TI; Dmitrovskiĭ AM
    Zh Mikrobiol Epidemiol Immunobiol; 1993; (6):81-2. PubMed ID: 8079585
    [No Abstract]   [Full Text] [Related]  

  • 35. Studies on the contribution of the F1 capsule-associated plasmid pFra to the virulence of Yersinia pestis.
    Welkos SL; Davis KM; Pitt LM; Worsham PL; Freidlander AM
    Contrib Microbiol Immunol; 1995; 13():299-305. PubMed ID: 8833858
    [No Abstract]   [Full Text] [Related]  

  • 36. Immunogenicity of Yersiniae.
    Mazigh D; Quilici ML; Mollaret HH
    Contrib Microbiol Immunol; 1987; 9():304-11. PubMed ID: 3665511
    [No Abstract]   [Full Text] [Related]  

  • 37. The structure of Yersinia pestis Caf1 polymer in free and adjuvant bound states.
    Soliakov A; Harris JR; Watkinson A; Lakey JH
    Vaccine; 2010 Aug; 28(35):5746-54. PubMed ID: 20600492
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sepsis-enhancing effect of cobalt-60 irradiation in mice infected with virulent Yersinia pestis on the same day or seven days later.
    Wake A; Long PV; Hien HG; Hirota K
    Contrib Microbiol Immunol; 1995; 13():273-6. PubMed ID: 8833852
    [No Abstract]   [Full Text] [Related]  

  • 39. [Effect of immunomodulators of organometallic nature on the sensitivity to plague toxin].
    Kirillicheva GB; Baturina IG; Rozhkov KK; Ignatenko MA
    Biull Eksp Biol Med; 1993 Mar; 115(3):282-4. PubMed ID: 8054625
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunochemical characteristics of the autoagglutination factor of plague pathogen].
    Rykova VA; Lysova LK; Podladchikova ON
    Klin Lab Diagn; 2009 Mar; (3):19-22. PubMed ID: 19388480
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.